Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | ADH1B | P00325 | 1/20 | 0.37 |
| ▸ | ADH1C | P00326 | 1/20 | 0.37 |
| ▸ | ADH1A | P07327 | 1/20 | 0.37 |
| ▸ | ADH4 | P08319 | 1/20 | 0.37 |
| ▸ | ADH7 | P40394 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | MMP1 | P03956 | 1/20 | 0.35 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | MMP3 | P08254 | 1/20 | 0.35 |
| ▸ | MMP9 | P14780 | 1/20 | 0.35 |
| ▸ | MMP8 | P22894 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9979182 | 1.00 | EPHX1 (0.43) | EPHX1HPGDKMT2ACYP1A2ADH1B | |
| SCHEMBL5117 | 1.00 | EPHX1 (0.43) | EPHX1HPGDKMT2ACYP1A2ADH1B | |
| SCHEMBL9253989 | 1.00 | EPHX1 (0.43) | EPHX1HPGDKMT2ACYP1A2ADH1B | |
| SCHEMBL3032405 | 1.00 | EPHX1 (0.43) | EPHX1HPGDKMT2ACYP1A2ADH1B | |
| SCHEMBL5708 | 1.00 | EPHX1 (0.43) | EPHX1HPGDKMT2ACYP1A2ADH1B | |
| SCHEMBL5021 | 0.97 | — | — | |
| SCHEMBL5688 | 0.91 | — | — | |
| SCHEMBL349125 | 0.84 | — | — | |
| Cyclohexane SCHEMBL1245516 | 0.78 | EPHX1 (0.50) | EPHX1HPGDKMT2AADH1BADH1C | |
| SCHEMBL3069324 | 0.78 | EPHX1 (0.40) | EPHX1HPGDKMT2ACYP1A2ADH1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 397 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109963886-B | Phosphoguanidine group IV metal olefin polymerization catalyst | 陶氏环球技术有限责任公司 | 2023-01-06 | — | — | CN | claimed |
| US-11066495-B2 | Phosphaguanidine group IV metal olefin polymerization catalysts | DOW GLOBAL TECHNOLOGY LLC (US) | 2021-07-20 | — | — | US | claimed |
| EP-3519470-B1 | PHOSPHAGUANIDINE GROUP IV METAL OLEFIN POLYMERIZATION CATALYSTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-10-21 | — | — | EP | claimed |
| US-20200031960-A1 | PHOSPHAGUANIDINE GROUP IV METAL OLEFIN POLYMERIZATION CATALYSTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-01-30 | — | — | US | claimed |
| EP-3519470-A1 | PHOSPHAGUANIDINE GROUP IV METAL OLEFIN POLYMERIZATION CATALYSTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-08-07 | — | — | EP | claimed |
| CN-109963886-A | Phospha guanidine IV race metal olefin polymerization catalyst | 陶氏环球技术有限责任公司 | 2019-07-02 | — | — | CN | claimed |
| CN-107987196-A | For catalyst constituent for olefinic polymerization and its catalyst | 中国石油化工股份有限公司 | 2018-05-04 | — | — | CN | claimed |
| WO-2018064493-A1 | PHOSPHAGUANIDINE GROUP IV METAL OLEFIN POLYMERIZATION CATALYSTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-04-05 | — | — | WO | claimed |
| CN-103788237-B | Catalyst solid constituent and catalyst thereof with and application in olefinic polymerization | SINOPEC CORP. (CN) | 2016-05-25 | — | — | CN | claimed |
| US-6184385-B1 | NOVEL METHOD FOR RECOVERING THE PRODUCT, ADDITION OF WATER TO THE SOLVENT SLURRY AND THE ISOLATING OF THE PRODUCT BY A SINGLE FILTRATION STEP, SANTOCURE? | FLEXSYS AMERICA L.P. | 2001-02-06 | — | — | US | claimed |
| CN-113939546-B | Aqueous polymer dispersion and method for producing same | 陶氏环球技术有限责任公司 | 2023-11-28 | — | — | CN | disclosed |
| WO-2023101004-A1 | OLEFIN RESIN, METHOD FOR MANUFACTURING SAME, AND APPLICATION FOR SAME | 三井化学株式会社 | 2023-06-08 | — | — | WO | disclosed |
| US-20230099694-A1 | PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2023-03-30 | — | — | US | disclosed |
| US-20230057670-A1 | NON-AQUEOUS ELECTROLYTE AND ENERGY DEVICE USING SAID NON-AQUEOUS ELECTROLYTE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-02-23 | — | — | US | disclosed |
| EP-4123781-A1 | NON-AQUEOUS ELECTROLYTE AND ENERGY DEVICE USING SAID NON-AQUEOUS ELECTROLYTE | Mitsubishi Chemical Corporation (JP) | 2023-01-25 | — | — | EP | disclosed |
| EP-0049071-A1 | N-arylbenzamide derivatives | ELI LILLY AND COMPANY (US) | 1982-04-07 | — | — | EP | disclosed |
| US-4298739-A | ANTICOAGULANTS, ANTIINFLAMMATORY, ANTIULCER, VASODILATOR, PHOSPHODIESTERASE INHIBITORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1981-11-03 | — | — | US | disclosed |
| EP-0035046-A1 | Novel tetrazole derivatives, process for the preparation thereof, and anti-ulcer composition containing the same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1981-09-09 | — | — | EP | disclosed |
| US-4277479-A | ANTI-ASTHMATIC, HYPOTENSIVE, ANTI-ULCER, ANTIINFLAMMATORY, VASODILATION, ENZYME INHIBITORS, ANTICOAGULANTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1981-07-07 | — | — | US | disclosed |
| US-4071527-A | Certain benzothiazole compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1978-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230099694-A1 | PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS | SUZ12, BRPF3, BRD4 | EPHX1 970/4885HPGD 2931/4885KMT2A 320/4885 |
| US-11066495-B2 | Phosphaguanidine group IV metal olefin polymerization catalysts | POLG, ODC1, RNGTT | EPHX1 3805/4885HPGD 487/4885KMT2A 3113/4885 |
| US-20200031960-A1 | PHOSPHAGUANIDINE GROUP IV METAL OLEFIN POLYMERIZATION CATALYSTS | POLG, ODC1, RNGTT | EPHX1 3805/4885HPGD 487/4885KMT2A 3113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.